Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Cannabis-based medicines for chronic neuropathic pain in adults
Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub2 · Cited by 571
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Neuropathic Pain: Principles of Diagnosis and Treatment
Gilron, I., Baron, R., & Jensen, T. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.018 · Cited by 540
Self-citationEtiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
Pregabalin for neuropathic pain in adults
Derry, S., Bell, R. F., Straube, S., Wiffen, P. J., Aldington, D., & Moore, R. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub3 · Cited by 364
Challenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Amitriptyline for neuropathic pain in adults
Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008242.pub3 · Cited by 286
Wang, L., Hong, P. J., May, C., Rehman, Y., Oparin, Y., Hong, C. J., Hong, B. Y., AminiLari, M., Gallo, L., Kaushal, A., et al. (2021) · BMJ · doi:10.1136/bmj.n1034 · Cited by 300
Self-citationPharmacologic interventions for treating phantom limb pain
Alviar, M. J. M., Hale, T., & Lim-Dungca, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006380.pub3 · Cited by 279
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 272
Baron, E. P. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 251
Pain Assessment and Treatment in Children With Significant Impairment of the Central Nervous System
Hauer, J., Houtrow, A. J., SECTION ON HOSPICE AND PALLIATIVE MEDICINE, C. O. C. W. D., Feudtner, C., Klein, S., Klick, J., Linebarger, J., Norwood, K. W., Adams, R. C., Brei, T. J., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1002 · Cited by 227
Therapeutic Approaches for Peripheral and Central Neuropathic Pain
Szok, D., Tajti, J., Nyári, A., Vécsei, L., & Trojano, L. (2019) · Behavioural Neurology · doi:10.1155/2019/8685954 · Cited by 217
Pathology of pain and its implications for therapeutic interventions
Cao, B., Xu, Q., Shi, Y., Zhao, R., Li, H., Zheng, J., Liu, F., Wan, Y., & Wei, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01845-w · Cited by 195
A review of Neuropathic Pain: From Guidelines to Clinical Practice
Cruccu, G., & Truini, A. (2017) · Pain and Therapy · doi:10.1007/s40122-017-0087-0 · Cited by 197
Sibbald, R. G., Elliott, J. A., Persaud-Jaimangal, R., Goodman, L., Armstrong, D. G., Harley, C., Coelho, S., Xi, N., Evans, R., Mayer, D. O., et al. (2021) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000733724.87630.d6 · Cited by 192
Pharmacological treatments of neuropathic pain: The latest recommendations
Attal, N. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.005 · Cited by 193
Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 177
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
Meng, H., Johnston, B., Englesakis, M., Moulin, D. E., & Bhatia, A. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002110 · Cited by 169
Self-citationPharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?
Attal, N., & Bouhassira, D. (2015) · Pain · doi:10.1097/01.j.pain.0000460358.01998.15 · Cited by 167
Central Neuropathic Pain Syndromes
Watson, J. C., & Sandroni, P. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.017 · Cited by 158
Häuser, W., Petzke, F., & Fitzcharles, M. A. (2018) · European Journal of Pain · doi:10.1002/ejp.1118 · Cited by 175
Fabry Disease: The Current Treatment Landscape
Lenders, M., & Brand, E. (2021) · Drugs · doi:10.1007/s40265-021-01486-1 · Cited by 160
Antidepressants for pain management in adults with chronic pain: a network meta-analysis
Birkinshaw, H., Friedrich, C., Cole, P., Eccleston, C., Serfaty, M. A., Stewart, G. B., White, S. P., Moore, A., Phillippo, D., & Pincus, T. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014682.pub2 · Cited by 221
Small fiber neuropathy: Getting bigger!
Chan, A. C. Y., & Wilder-Smith, E. P. (2016) · Muscle & Nerve · doi:10.1002/mus.25082 · Cited by 159
Pregabalin and gabapentin for pain
Mathieson, S., Lin, C. C., Underwood, M. R., & Eldabe, S. S. (2020) · BMJ · doi:10.1136/bmj.m1315 · Cited by 151
Slivicki, R. A., Xu, Z., Kulkarni, P. M., Pertwee, R. G., Mackie, K., Thakur, G. A., & Hohmann, A. G. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.032 · Cited by 144
Advances and challenges in neuropathic pain: a narrative review and future directions
Attal, N., Bouhassira, D., & Colvin, L. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.04.021 · Cited by 171
Onakpoya, I. J., Thomas, E. T., Lee, J. J., Goldacre, B., & Heneghan, C. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023600 · Cited by 132
The endocannabinoid system and neuropathic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000428 · Cited by 145
Mu, A., Weinberg, E. L., Moulin, D. E., & Clarke, H. A. (2017) · Europe PMC (PubMed Central) · Cited by 125
Self-citationClinical practice guidelines for the management of neuropathic pain: a systematic review
Deng, Y.-K., Luo, L., Hu, Y., Fang, K., & Liu, J. (2015) · BMC Anesthesiology · doi:10.1186/s12871-015-0150-5 · Cited by 118
Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment
Politei, J. M., Bouhassira, D., Germain, D. P., Goizet, C., Guerrero-Sola, A., Hilz, M. J., Hutton, E. J., Karaa, A., Liguori, R., Üçeyler, N., et al. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12542 · Cited by 131
Huang, A., Azam, A., Segal, S., Pivovarov, K., Katznelson, G., Ladak, S. S., Mu, A., Weinrib, A., Katz, J., & Clarke, H. (2016) · Pain Management · doi:10.2217/pmt-2016-0004 · Cited by 115
Self-citationTreating Painful Diabetic Peripheral Neuropathy: An Update.
Snyder, M. J., Gibbs, L. M., & Lindsay, T. J. (2016) · PubMed · Cited by 115
Zilliox, L. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000462 · Cited by 168
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice
Segat, G. C., Manjavachi, M. N., Matias, D. O., Passos, G. F., Freitas, C. S., da Costa, R., & Calixto, J. Β. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.015 · Cited by 118
The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence
Boyaji, S., Merkow, J. S., Elman, R. N. M., Kaye, A. D., Yong, R. J., & Urman, R. D. (2020) · Current Pain and Headache Reports · doi:10.1007/s11916-020-0835-4 · Cited by 147
America’s Opioid Epidemic: Supply and Demand Considerations
Clark, J. D., & Schumacher, M. A. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002388 · Cited by 114
Guy, S. D., Mehta, S., Casalino, A., Côté, I., Kras‐Dupuis, A., Moulin, D. E., Parrent, A. G., Potter, P. J., Short, C., Teasell, R. W., et al. (2016) · Spinal Cord · doi:10.1038/sc.2016.90 · Cited by 107
Self-citationBalanaser, M., Carley, M. E., Baron, R., Finnerup, N. B., Moore, A., Rowbotham, M. C., Chaparro, L. E., & Gilron, I. (2022) · Pain · doi:10.1097/j.pain.0000000000002688 · Cited by 115
Self-citationZiegler, D., Duan, W. R., An, G., Thomas, J. W., & Nothaft, W. (2015) · Pain · doi:10.1097/j.pain.0000000000000263 · Cited by 100
Interventions for Neuropathic Pain: An Overview of Systematic Reviews
Došenović, S., Kadić, A. J., Miljanović, M., Biocić, M., Borić, K., Ćavar, M., Markovina, N., Vučić, K., & Puljak, L. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001998 · Cited by 114
Preventive Analgesia and Novel Strategies for the Prevention of Chronic Post-Surgical Pain
Clarke, H., Poon, M., Weinrib, A., Katznelson, R., Wentlandt, K., & Katz, J. (2015) · Drugs · doi:10.1007/s40265-015-0365-2 · Cited by 98
Self-citationCannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
Petzke, F. W., Tölle, T. R., Fitzcharles, M., & Häuser, W. (2021) · CNS Drugs · doi:10.1007/s40263-021-00879-w · Cited by 106
Massart, R., Dymov, S., Millecamps, M., Suderman, M. J., Grégoire, S., Koenigs, K., Alvarado, S. G., Tajerian, M., Stone, L. S., & Szyf, M. (2016) · Scientific Reports · doi:10.1038/srep19615 · Cited by 97
Managing Neuropathic Pain in Dogs
Moore, S. A. (2016) · Frontiers in Veterinary Science · doi:10.3389/fvets.2016.00012 · Cited by 123
Combination of morphine with nortriptyline for neuropathic pain
Gilron, I., Tu, D., Holden, R. R., Jackson, A. C., & Dumerton-Shore, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000149 · Cited by 96
Self-citationCannabinoids in Pain Management and Palliative Medicine
Häuser, W., Fitzcharles, M., Radbruch, L., & Petzke, F. W. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0627 · Cited by 117
Alles, S. R. A., & Smith, P. A. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.750583 · Cited by 96
Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research
Leitzelar, B. N., & Koltyn, K. F. (2021) · Sports Medicine - Open · doi:10.1186/s40798-021-00307-9 · Cited by 99
Sex and gender considerations in Canadian clinical practice guidelines: a systematic review
Tannenbaum, C., Clow, B., Haworth-Brockman, M. J., & Voss, P. (2017) · CMAJ Open · doi:10.9778/cmajo.20160051 · Cited by 92
Management of Central Poststroke Pain: Systematic Review of Randomized Controlled Trials
Mulla, S. M., Wang, L., Khokhar, R., Izhar, Z., Agarwal, A., Couban, R., Buckley, D. N., Moulin, D. E., Panju, A. A., Makosso‐Kallyth, S., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010259 · Cited by 97
Self-citationPetzke, F., Enax-Krumova, E. K., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0089-y · Cited by 80
Antidepressants for chronic non-cancer pain in children and adolescents
Cooper, T. E., Heathcote, L. C., Clinch, J., Gold, J. I., Howard, R. F., Lord, S. M., Schechter, N. L., Wood, C. H., & Wiffen, P. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012535.pub2 · Cited by 90
Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution
Costa, B., & Vale, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076050 · Cited by 88
A User’s Guide to Cannabinoid Therapies in Oncology
Maida, V., & Daeninck, P. J. (2016) · Current Oncology · doi:10.3747/co.23.3487 · Cited by 90
The Antinociceptive Properties of the Corydalis yanhusuo Extract
Wang, L., Zhang, Y., Wang, Z., Gong, N., Kweon, T. D., Vo, B., Wang, C., Zhang, X., Chung, J. Y., Alachkar, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162875 · Cited by 78
Friesen, K. J., Chateau, D., Falk, J., Alessi‐Severini, S., & Bugden, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2185-3 · Cited by 74
Qin, C., Wu, M., Xu, S., Wang, X., Shi, W., Dong, Y., Yang, L., He, W., Han, X., & Yin, L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.011 · Cited by 74
Nabilone for the Management of Pain
Tsang, C. C., & Giudice, M. G. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1709 · Cited by 73
Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain
Burness, C. B., & McCormack, P. L. (2015) · Drugs · doi:10.1007/s40265-015-0520-9 · Cited by 73
Post-herpetic neuralgia – a review of current management and future directions
Schutzer-Weissmann, J. M., & Farquhar-Smith, P. W. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1392508 · Cited by 77
Schlereth, T. (2020) · Neurological Research and Practice · doi:10.1186/s42466-020-00063-3 · Cited by 77
Not All Pain is Created Equal: Basic Definitions and Diagnostic Work-Up
Bonezzi, C., Fornasari, D., Cricelli, C. A., Magni, A., & Ventriglia, G. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00217-w · Cited by 92
Utility of lidocaine as a topical analgesic and improvements in patch delivery systems
Gudin, J., & Nalamachu, S. R. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2019.1702296 · Cited by 75
Safety Considerations in Cannabinoid-Based Medicine
Gottschling, S., Ayonrinde, O., Bhaskar, A., Blockman, M., D’Agnone, O., Schecter, D., Rodríguez, L. D. S., Yafai, S., & Cyr, C. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s275049 · Cited by 73
Methadone for neuropathic pain in adults
McNicol, E. D., Ferguson, M. C., & Schumann, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012499.pub2 · Cited by 78
Guo, J., Wang, H., Xiao-ju, J., Jia, D., Zhou, X., & Tao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17629 · Cited by 69
RetractedSystematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury: An Update
Mehta, S., McIntyre, A., Janzen, S. E., Loh, E., & Teasell, R. W. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.12.023 · Cited by 68
Moustafa, P. E., Abdelkader, N. F., Awdan, S. A. E., El‐Shabrawy, O. A., & Zaki, H. F. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14336 · Cited by 68
Topical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum
Maida, V., & Corban, J. P. A. H. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.06.005 · Cited by 66
Can pregabalin prevent paclitaxel-associated neuropathy?—An ACCRU pilot trial
Shinde, S. S., Seisler, D. K., Soori, G. S., Atherton, P. J., Pachman, D. R., Lafky, J. M., Ruddy, K. J., & Loprinzi, C. L. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2807-5 · Cited by 67
Henssen, D. J. H. A., Derks, B., van Doorn, M., Verhoogt, N., van Walsum, A. V. C., Staats, P. S., & Vissers, K. C. P. (2019) · Cephalalgia · doi:10.1177/0333102419833076 · Cited by 64
S2k-Leitlinie: Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen
Schlereth, T. (2019) · DGNeurologie · doi:10.1007/s42451-019-00139-8 · Cited by 65
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
McAnally, H. B., Bonnet, U., & Kaye, A. D. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00189-x · Cited by 66
Häuser, W., Petzke, F. W., Radbruch, L., & Tölle, T. R. (2016) · Pain Management · doi:10.2217/pmt.16.5 · Cited by 71
Sun, W., Larson, M. J. E., Kiyoshi, C. M., Annett, A. J., Stalker, W. A., Peng, J., & Tedeschi, A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130391 · Cited by 64
Nathan, H. J., Poulin, P., Wozny, D., Taljaard, M., Smyth, C., Gilron, I., Sorisky, A., Lochnan, H., & Shergill, Y. (2017) · Clinical Diabetes · doi:10.2337/cd17-0077 · Cited by 61
“Current evidence indicates that pharmacotherapy for neuropathic pain provides only partial pain relief, is not well tolerated (and therefore cannot be used) by many patients, and is associated with effects that can adversely affect patient safety and quality of life (QoL) (5,6).”
BackgroundSelf-citationAl-Khazaleh, A. K., Zhou, X., Bhuyan, D. J., Münch, G. W., Al-Dalabeeh, E. A., Jaye, K. M., & Chang, D. (2024) · Molecules · doi:10.3390/molecules29020410 · Cited by 79
Zhou, L. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1688977 · Cited by 65
A Targeted Approach to Post-Mastectomy Pain and Persistent Pain following Breast Cancer Treatment
Chang, P. J., Asher, A., & Smith, S. R. (2021) · Cancers · doi:10.3390/cancers13205191 · Cited by 74
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Campos, R. M. P., Aguiar, A. F. L., Paes-Colli, Y., Trindade, P. M. P., Ferreira, B. K., Reis, R. A. D. M., & Sampaio, L. D. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.785176 · Cited by 69
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies
Temmermand, R., Barrett, J. E., & Fontana, A. C. K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106492 · Cited by 69
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012227.pub2 · Cited by 67
Pagé, M. G., Fortier, M., Ware, M. A., & Choinière, M. (2018) · Journal of Pain Research · doi:10.2147/jpr.s149262 · Cited by 59
Self-citationTreating persistent pain after breast cancer surgery
Khan, J. S., Ladha, K. S., Abdallah, F., & Clarke, H. (2020) · Drugs · doi:10.1007/s40265-019-01227-5 · Cited by 57
Self-citationPharmacological Management of Chronic Pelvic Pain in Women
Carey, E. T., Till, S. R., & As‐Sanie, S. (2017) · Drugs · doi:10.1007/s40265-016-0687-8 · Cited by 57
The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective
Podvin, S., Yaksh, T. L., & HOOK, V. Y. H. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103042 · Cited by 63
Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression
Benson, C. A., Mifflin, K. A., Kerr, B. J., Jesudasan, S. J. B., Dursun, S. M., & Baker, G. B. (2015) · Modern trends in psychiatry · doi:10.1159/000435933 · Cited by 61
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Mouhamed, Y., Vishnyakov, A., Qorri, B., Sambi, M., Frank, S. M. S., Nowierski, C., Lamba, A., Bhatti, U., & Szewczuk, M. R. (2018) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s158592 · Cited by 63
Update on the Management of Diabetic Neuropathy
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0036 · Cited by 55
Shahid, M. M., Subhan, F., Ahmad, N., Ali, G., Akbar, S., Fawad, K., & Sewell, R. D. E. (2016) · European Journal of Pain · doi:10.1002/ejp.971 · Cited by 58
Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study
Moulin, D. E., Clark, A. J., GORDON, A. S., Lynch, M. E., Morley-Forster, P., Nathan, H., Smyth, C., Toth, C. C., VanDenKerkhof, E. G., Gilani, A. A., et al. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.05.011 · Cited by 56
Self-citationEfficacy of Venlafaxine in Neuropathic Pain: A Narrative Review of Optimized Treatment
Trouvin, A., Perrot, S., & Lloret‐Linares, C. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.05.347 · Cited by 53
Wong, S. S. C., Chan, W. S., & Cheung, C. W. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09905-y · Cited by 62
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.